Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30

$2.08−0.13 (-5.88%)

Close on Nov 13, 2026Market cap $1.70MP/E –Yield –

Genprex ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Genprex has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?